Home / Editorial Board
Editorial board.
The board is being constituted. Structure is shown below; named appointments will be announced with the inaugural issue.
Editorial leadership
Editor-in-Chief
Full editorial authority; appointed by the SIRiiM Board on recommendation of the Publications Committee.
Deputy Editor
Shares handling load; acts for the Editor-in-Chief on conflicted manuscripts.
Statistical Editor
Reviews analytic methods for all quantitative submissions.
Section editors
Screening
Risk modeling, imaging strategy, early-detection biomarkers.
Surveillance
Response assessment, MRD, longitudinal immune monitoring.
Survivorship
Late effects, second malignancy, patient-reported outcomes.
Radiation Immunobiology
Mechanism, immunogenic cell death, interferon signaling.
Combination Therapeutics
Radiation with checkpoint blockade, cell therapy, and bispecifics.
Physics & Immune-Sparing Planning
Dose, volume, and technique in service of immune preservation.
Editorial board members
The full editorial board will comprise 30–45 members with deliberate breadth across radiation oncology, tumor immunology, radiobiology, medical physics, epidemiology, and survivorship care, and across geographic regions. Board terms will run three years, renewable once.